Track electroCore, Inc. — Monitor price, dividends, and performance in your free portfolio

Start Tracking Free

electroCore, Inc. ECOR Open electroCore, Inc. in new tab

6.80 USD
EPS
-1.65
P/B
-27.38
ROE
-478.70
Beta
0.50
Target Price
19.80 USD
electroCore, Inc. logo

electroCore, Inc.

🧾 Earnings Recap – Q3 2025

electroCore's Q3 2025 results reflect a strategic pivot aimed at accelerating growth through key investments and acquisitions, despite a temporary delay in profitability.

  • Delivered robust revenue growth in the VA channel, secured a new 5-year contract, and expanded sales capabilities.
  • Acquired NeuroMetrix's Quell portfolio, enhancing product offerings and diversifying revenue streams with a new FDA-cleared device for fibromyalgia.
  • Initiated targeted investments in technology and personnel to support growth in both medical and wellness divisions, positioning the company for future success.
📅
1M 6M YTD 1Y 2Y 5Y Max
Loading chart...
Key Metrics
Earnings dateApril 30, 2026
EPS-1.65
Book Value-0.21
Price to Book-27.38
Debt/Equity380.32
% Insiders36.748%
Growth
Revenue Growth0.31%
Estimates
Forward P/E-10.65
Forward EPS-0.55
Target Mean Price19.80

DCF Valuation

Tweak assumptions to recompute fair value for electroCore, Inc. (ECOR)
Currency: USD
DCF Assumptions
Decimal (e.g., 0.10 = 10%). Range allows declines (−50%) to strong growth (+50%).
Decimal (e.g., 0.30 = 30%).
Decimal (e.g., 0.04 = 4%).
Decimal (e.g., 0.20 = 20%).
Percent number (e.g., 3 = 3%).
Percent number (e.g., 10 = 10%).
Percent number (e.g., 5 = 5%).
DCF Result
Fair Value (DCF)
—
Current Price
—
Upside
—
WACC
—
Terminal PV
—
Σ PV of FCFs
—
Note: historical bars show reported FCF (for context); forward bars show PV of projected FCF; if no per-year data, totals are shown.

electroCore, Inc. Logo electroCore, Inc. Analysis (ECOR)

United States Health Care Official Website Stock

Is electroCore, Inc. a good investment? electroCore, Inc. (ECOR) is currently trading at 6.80 USD. Market analysts have a consensus price target of 19.80 USD. This suggests a potential upside from current levels.

Earnings Schedule: electroCore, Inc. is expected to release its next earnings report on April 30, 2026. The market consensus estimate for Forward EPS is -0.55.

Investor FAQ

Does electroCore, Inc. pay a dividend?

No, it does not currently pay a dividend.

What asset class is electroCore, Inc.?

electroCore, Inc. is classified as a Stock. You can compare it against its peer in the "Related Symbols" list.

When is the next earnings date?

The next earnings date is projected to be April 30, 2026. The company currently has a trailing EPS of -1.65.

Company Profile

electroCore, Inc., a bioelectronic technology medicine and general wellness company, provides non-invasive vagus nerve stimulation (nVNS) technology platform in the United States, the United Kingdom, and internationally. The company develops gammaCore, a prescription only handheld device intended for regular or intermittent use for the acute treatment of pain associated with migraine and episodic cluster headache, as well as for the treatment of hemicrania continua and paroxysmal hemicrania. It also develops Truvaga 350, a personal use consumer electronics general wellness product and Truvaga Plus, an app-enabled general wellness product. It also offers non-invasive bioelectronic therapies for the treatment of chronic pain and wellness conditions. In addition, the company offers TAC-STIM for human performance and gammaCore Sapphire, a portable, reusable, rechargeable, and reloadable prescription medical device for various primary headache conditions. electroCore, Inc. was incorporated in 2005 and is headquartered in Rockaway, New Jersey.

Exchange Ticker
NMS (United States) ECOR

Dividends

Historical Split Corporate Actions

Split Date Split Ratio to 1
Feb. 15, 2023 0.070000
Trades
Trade History
No trades yet
Explore Premium Features

Unlock detailed news and exclusive insights with our Premium subscription.

See Pricing Plans

Under Construction

This feature will be available soon. Stay tuned!

Follow us on Twitter for updates: @allinvestview

Check out our Roadmap for upcoming features.

Community Discussion